Observational Study to Evaluate the Safety of DILATREND SR Cap. in Korean Patients With Essential Hypertension, Chronic Stable Angina and Congestive Heart Failure

NCT03063697 · clinicaltrials.gov ↗

UNKNOWN

Status

20000

Enrollment

INDUSTRY

Sponsor class

Conditions

Essential Hypertension
Chronic Stable Angina
Congestive Heart Failure

Sponsor

Chong Kun Dang Pharmaceutical